• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sleep positioning systems for children with cerebral palsy.针对脑瘫儿童的睡眠体位系统。
Cochrane Database Syst Rev. 2015;2015(11):CD009257. doi: 10.1002/14651858.CD009257.pub2. Epub 2015 Nov 2.
2
Technological aids for the rehabilitation of memory and executive functioning in children and adolescents with acquired brain injury.脑损伤儿童和青少年记忆与执行功能康复的技术辅助手段。
Cochrane Database Syst Rev. 2016 Jul 1;7(7):CD011020. doi: 10.1002/14651858.CD011020.pub2.
3
Education support services for improving school engagement and academic performance of children and adolescents with a chronic health condition.改善患有慢性病的儿童和青少年的学校参与度和学业成绩的教育支持服务。
Cochrane Database Syst Rev. 2023 Feb 8;2(2):CD011538. doi: 10.1002/14651858.CD011538.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
7
Antidepressants for chronic non-cancer pain in children and adolescents.用于治疗儿童和青少年慢性非癌性疼痛的抗抑郁药。
Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012535. doi: 10.1002/14651858.CD012535.pub2.
8
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
9
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.
10
Antiepileptic drugs for chronic non-cancer pain in children and adolescents.用于儿童和青少年慢性非癌性疼痛的抗癫痫药物。
Cochrane Database Syst Rev. 2017 Aug 5;8(8):CD012536. doi: 10.1002/14651858.CD012536.pub2.

引用本文的文献

1
Ottawa nutritional guide intervention for nausea and vomiting in pregnancy: a randomized controlled trial protocol.渥太华营养指南对妊娠期恶心和呕吐的干预:一项随机对照试验方案
Reprod Health. 2025 Aug 11;22(1):146. doi: 10.1186/s12978-025-02097-9.
2
Evidence for 24-hour posture management: A scoping review.24小时姿势管理的证据:一项范围综述。
Br J Occup Ther. 2023 Mar;86(3):176-187. doi: 10.1177/03080226221148414. Epub 2023 Jan 12.
3
Cerebral palsy and sleep: nonpharmacological treatment and impact on the life of caregivers - an integrative review.脑性瘫痪与睡眠:非药物治疗及其对照顾者生活的影响——综合评价。
Arq Neuropsiquiatr. 2024 Mar;82(3):1-9. doi: 10.1055/s-0044-1781464. Epub 2024 Mar 11.
4
Prevention of hip dislocation in severe cerebral palsy (GMFCS III-IV-V): an interdisciplinary and multi-professional Care Pathway for clinical best practice implementation.预防严重脑瘫(GMFCS III-IV-V)患者髋关节脱位:临床最佳实践实施的跨学科多专业护理路径。
Eur J Phys Rehabil Med. 2023 Dec;59(6):714-723. doi: 10.23736/S1973-9087.23.07978-9. Epub 2023 Oct 5.
5
[Otorhinolaryngological diseases in pregnancy-which drugs are approved?].[妊娠期耳鼻咽喉科疾病——哪些药物是获批的?]
HNO. 2022 Mar;70(3):239-248. doi: 10.1007/s00106-021-01144-8. Epub 2022 Jan 24.
6
State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy.证据现状交通灯 2019:预防和治疗脑瘫儿童干预措施的系统评价。
Curr Neurol Neurosci Rep. 2020 Feb 21;20(2):3. doi: 10.1007/s11910-020-1022-z.

本文引用的文献

1
Technical devices in children with motor disabilities: a review.运动障碍儿童的技术设备:综述
Disabil Rehabil Assist Technol. 2014 Jan;9(1):3-11. doi: 10.3109/17483107.2013.785034. Epub 2013 Apr 18.
2
Ventilatory function in children with severe motor disorders using night-time postural equipment.夜间姿势设备对严重运动障碍儿童通气功能的影响。
Dev Med Child Neurol. 2013 Aug;55(8):751-7. doi: 10.1111/dmcn.12149. Epub 2013 Apr 15.
3
The Consensus Statement on Hip Surveillance for Children with Cerebral Palsy: Australian Standards of Care.《脑瘫患儿髋关节监测共识声明:澳大利亚护理标准》
J Pediatr Rehabil Med. 2011;4(3):183-95. doi: 10.3233/PRM-2011-0174.
4
The use of night orthoses in cerebral palsy treatment: sleep disturbance in children and parental burden or not?脑瘫治疗中夜用矫形器的使用:是否会引起儿童睡眠障碍和家长负担?
Res Dev Disabil. 2012 Mar-Apr;33(2):341-9. doi: 10.1016/j.ridd.2011.10.026. Epub 2011 Nov 25.
5
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?n-of-1临床试验:个体化医疗的终极策略?
Per Med. 2011 Mar;8(2):161-173. doi: 10.2217/pme.11.7.
6
Sleep quality and respiratory function in children with severe cerebral palsy using night-time postural equipment: a pilot study.使用夜间体位设备对重度脑瘫患儿睡眠质量和呼吸功能的初步研究
Acta Paediatr. 2009 Nov;98(11):1809-14. doi: 10.1111/j.1651-2227.2009.01441.x. Epub 2009 Jul 22.
7
Assessing and managing lung disease and sleep disordered breathing in children with cerebral palsy.评估和管理脑瘫患儿的肺部疾病和睡眠呼吸障碍。
Paediatr Respir Rev. 2009 Mar;10(1):18-24. doi: 10.1016/j.prrv.2008.10.003. Epub 2009 Jan 23.
8
Hip subluxation and dislocation in cerebral palsy - a prospective study on the effectiveness of postural management programmes.脑瘫患儿的髋关节半脱位和脱位——姿势管理方案有效性的前瞻性研究
Physiother Res Int. 2009 Jun;14(2):116-27. doi: 10.1002/pri.434.
9
Continuous postural management and the prevention of deformity in children with cerebral palsy: an appraisal.脑瘫患儿的持续姿势管理与畸形预防:一项评估
Dev Med Child Neurol. 2009 Feb;51(2):105-10. doi: 10.1111/j.1469-8749.2008.03160.x.
10
Developing and evaluating complex interventions: the new Medical Research Council guidance.开发与评估复杂干预措施:医学研究理事会新指南
BMJ. 2008 Sep 29;337:a1655. doi: 10.1136/bmj.a1655.

针对脑瘫儿童的睡眠体位系统。

Sleep positioning systems for children with cerebral palsy.

作者信息

Blake Sharon F, Logan Stuart, Humphreys Ginny, Matthews Justin, Rogers Morwenna, Thompson-Coon Joanna, Wyatt Katrina, Morris Christopher

机构信息

Peninsula Cerebra Research Unit (PenCRU), University of Exeter Medical School, Room 008, Veysey Building, Salmon Pool Lane, Exeter, Devon, UK, EX2 4SG.

出版信息

Cochrane Database Syst Rev. 2015;2015(11):CD009257. doi: 10.1002/14651858.CD009257.pub2. Epub 2015 Nov 2.

DOI:10.1002/14651858.CD009257.pub2
PMID:26524348
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8761500/
Abstract

BACKGROUND

Sleep positioning systems can be prescribed for children with cerebral palsy to help reduce or prevent hip migration, provide comfort to ease pain and/or improve sleep. As sleep disturbance is common in children with developmental disabilities, with impact on their carers' sleep, and as sleep positioning systems can be expensive, guidance is needed to support decisions as to their use.

OBJECTIVES

To determine whether commercially-available sleep positioning systems, compared with usual care, reduce or prevent hip migration in children with cerebral palsy. Any negative effect of sleep positioning systems on hip migration will be considered within this objective.Secondary objectives were to determine the effect of sleep positioning systems on: (1) number or frequency of hip problems; (2) sleep patterns and quality; (3) quality of life of the child and family; (4) pain; and (5) physical functioning. We also sought to identify any adverse effects from using sleep positioning systems.

SEARCH METHODS

In December 2014, we searched CENTRAL, Ovid MEDLINE, Embase, and 13 other databases. We also searched two trials registers. We applied no restrictions on date of publication, language, publication status or study design. We checked references and contacted manufacturers and authors for potentially relevant literature, and searched the internet using Google.

SELECTION CRITERIA

We included all randomised controlled trials (RCTs) evaluating whole body sleep positioning systems for children and adolescents (up to 18 years of age) with cerebral palsy.

DATA COLLECTION AND ANALYSIS

Two review authors independently screened reports retrieved from the search against pre-determined inclusion criteria and assessed the quality of eligible studies.Members of the public (parent carers of children with neurodisability) contributed to this review by suggesting the topic, refining the research objectives, interpreting the findings, and reviewing the plain language summary.

MAIN RESULTS

We did not identify any randomised controlled trials that evaluated the effectiveness of sleep positioning systems on hip migration.We did find two randomised cross-over trials that met the inclusion criteria in respect of secondary objectives relating to sleep quality and pain. Neither study reported any important difference between sleeping in sleep positioning systems and not for sleep patterns or sleep quality (two studies, 21 children, very low quality evidence) and pain (one study, 11 children, very low quality evidence). These were small studies with established users of sleep positioning systems and were judged to have high risk of bias.We found no eligible trials that explored the other secondary objectives (number or frequency of hip problems, quality of life of the child and family, physical functioning, and adverse effects).

AUTHORS' CONCLUSIONS: We found no randomised trials that evaluated the effectiveness of sleep positioning systems to reduce or prevent hip migration in children with cerebral palsy. Nor did we find any randomised trials that evaluated the effect of sleep positioning systems on the number or frequency of hip problems, quality of life of the child and family or on physical functioning.Limited data from two randomised trials, which evaluated the effectiveness of sleep positioning systems on sleep quality and pain for children with cerebral palsy, showed no significant differences in these aspects of health when children were using and not using a sleep positioning system.In order to inform clinical decision-making and the prescription of sleep positioning systems, more rigorous research is needed to determine effectiveness, cost-effectiveness, and the likelihood of adverse effects.

摘要

背景

可为脑瘫患儿开具睡眠定位系统,以帮助减少或预防髋关节移位,提供舒适感以缓解疼痛和/或改善睡眠。由于睡眠障碍在发育障碍儿童中很常见,会影响其照料者的睡眠,且睡眠定位系统可能价格昂贵,因此需要相关指导来支持关于其使用的决策。

目的

确定与常规护理相比,市售睡眠定位系统能否减少或预防脑瘫患儿的髋关节移位。在此目标范围内,将考虑睡眠定位系统对髋关节移位的任何负面影响。次要目标是确定睡眠定位系统对以下方面的影响:(1)髋关节问题的数量或频率;(2)睡眠模式和质量;(3)儿童及其家庭的生活质量;(4)疼痛;(5)身体功能。我们还试图确定使用睡眠定位系统的任何不良影响。

检索方法

2014年12月,我们检索了Cochrane系统评价数据库、Ovid MEDLINE、Embase以及其他13个数据库。我们还检索了两个试验注册库。我们对发表日期、语言、发表状态或研究设计均无限制。我们检查了参考文献,并联系了制造商和作者以获取潜在相关文献,还使用谷歌在互联网上进行了搜索。

入选标准

我们纳入了所有评估针对脑瘫儿童和青少年(至18岁)的全身睡眠定位系统的随机对照试验(RCT)。

数据收集与分析

两位综述作者独立根据预先确定的纳入标准筛选检索到的报告,并评估符合条件的研究的质量。公众(神经残疾儿童的家长照料者)通过提出主题、完善研究目标、解释研究结果以及审查通俗易懂的总结,对本综述做出了贡献。

主要结果

我们未找到任何评估睡眠定位系统对髋关节移位有效性的随机对照试验。我们确实找到了两项随机交叉试验,它们在与睡眠质量和疼痛相关的次要目标方面符合纳入标准。两项研究均未报告在使用睡眠定位系统睡眠和不使用睡眠定位系统睡眠之间,在睡眠模式或睡眠质量(两项研究,21名儿童,极低质量证据)以及疼痛方面(一项研究,11名儿童,极低质量证据)有任何重要差异。这些是针对睡眠定位系统现有使用者的小型研究,被判定存在高偏倚风险。我们未找到探索其他次要目标(髋关节问题的数量或频率、儿童及其家庭的生活质量、身体功能以及不良影响)的符合条件的试验。

作者结论

我们未找到评估睡眠定位系统减少或预防脑瘫患儿髋关节移位有效性 的随机试验。我们也未找到评估睡眠定位系统对髋关节问题的数量或频率、儿童及其家庭的生活质量或身体功能影响的随机试验。两项随机试验的有限数据评估了睡眠定位系统对脑瘫患儿睡眠质量和疼痛的有效性,结果显示在儿童使用和不使用睡眠定位系统时,这些健康方面无显著差异。为了为临床决策和睡眠定位系统的开具提供信息,需要更严格的研究来确定其有效性、成本效益以及不良影响的可能性。